Topline data is on track for anticipated readout in the summer of 2026WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- ...
Cystic fibrosis is among the most common, known and studied genetic diseases. It affects over 100,000 people worldwide and reduces life expectancy mainly as it causes lung and respiratory problems.
14h
Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch
This biotech innovator in cystic fibrosis therapies reported a notable insider sale amid a year of standout stock performance ...
1don MSN
Seattle family leads 'Great Strides' walk to fight cystic fibrosis through community and hope
Seattle Great Strides 2026 is set for May 17 at Seattle Center to support the Cystic Fibrosis Foundation's funding and ...
Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for ...
Malachy Reilly was a dedicated family man who gave lifelong support to the Cystic Fibrosis community
The local Cystic Fibrosis organisation has lost one of its great supporters and fundraisers following the recent death of ...
A cell-penetrating nanobody repairs misfolded CFTR proteins in cystic fibrosis cell models, restoring function and boosting ...
Joint Press Release from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie and Charité - Universitätsmedizin Berlin ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results